02/14/2025
4:38 PM | ARMISTICE CAPITAL, LLC (Filed by)
Checkpoint Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
8:00 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
7:30 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
8:00 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
8:00 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
4:27 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
5:26 PM | Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SCHEDULE 13D/A | |
12/20/2024
8:30 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
8:30 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:32 PM | Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:33 PM | Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CKPT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
12/17/2024
8:33 PM | Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:30 PM | Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:30 PM | Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:31 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:32 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
6:00 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/02/2024
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
08/19/2024
4:14 PM | Checkpoint Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/12/2024
3:40 PM | Checkpoint Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:45 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2024
3:05 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:05 PM | Checkpoint Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/03/2024
7:39 AM | Checkpoint Therapeutics (Filer)
| Form 424B5 | |
07/03/2024
7:44 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
7:00 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
7:01 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:46 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
8:00 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
8:01 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
3:05 PM | Checkpoint Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/24/2024
3:06 PM | Checkpoint Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/17/2024
4:13 PM | Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SC 13D/A | |
05/16/2024
6:33 PM | Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:34 PM | Amit Sharma (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:35 PM | Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:30 PM | Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:31 PM | Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:32 PM | Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
6:30 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:45 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Market down? Do this now. (Ad) During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now, history is repeating itself.
Here's the truth: Tariffs create uncertainty. Uncertainty drives investors to gold. And gold prices rise as a result. It's a cycle that's already beginning again—and it's your chance to profit.
Why wait? Greed isn't always a bad thing—especially when it comes to protecting and growing your wealth. The smartest investors are already moving their money into gold, and you should too. Download your Free 2025 Gold Guide Now |
04/07/2024
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
04/02/2024
5:00 AM | Checkpoint Therapeutics (Filer)
| Form DEF 14A | |
04/02/2024
5:03 AM | Checkpoint Therapeutics (Filer)
| Form DEFA14A | |
03/29/2024
4:03 PM | Checkpoint Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/22/2024
5:23 PM | Checkpoint Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
5:24 PM | Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SC 13D/A | |
03/22/2024
4:19 PM | Checkpoint Therapeutics (Filer)
| Form PRE 14A | |
03/22/2024
4:13 PM | Checkpoint Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/22/2024
7:52 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:00 PM | Amit Sharma (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/01/2024
7:30 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:31 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
